Modeling and Simulation - PK/PD Archives | Page 14 of 39 | Certara

Blog

The Model-informed Precision Dosing Revolution Is Coming

Modeling and simulation (M&S) has been widely accepted and adopted by biopharmaceutical companies and global…

CertaraMarch 7, 2017

Publication

CYP2C9 Genotype-dependent Warfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R- and S-Warfarin and Their Oxidative Metabolites

CertaraMarch 1, 2017

Publication

A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor

CertaraJanuary 10, 2017

Publication

Clarification of Contraceptive Drug Pharmacokinetics in Obesity

CertaraJanuary 1, 2017

Publication

Population Pharmacokinetics and Exposure-response of Osimertinib in Patients with Non-small Cell Lung Cancer

CertaraDecember 18, 2016

Brochure

Phoenix IVIVC Toolkit

Explore the comprehensive features of the IVIVC Toolkit.

CertaraDecember 14, 2016

Publication

Intravenous Topiramate: Pharmacokinetics in Dogs with Naturally Occurring Epilepsy

CertaraDecember 5, 2016

Publication

The Pharmacokinetics of Transdermal Flunixin Meglumine in Holstein Calves

This study describes the pharmacokinetics of topical and intravenous (IV) flunixin meglumine in Holstein calves.…

CertaraDecember 1, 2016

Publication

Modeling and Experimental Studies of Obeticholic Acid Exposure and the Impact of Cirrhosis Stage

CertaraDecember 1, 2016

Publication

Pharmacokinetics of Oral Terbinafine in Adult Horses

The primary study objective was to compare the pharmacokinetics of p.o. terbinafine alone to p.o.…

CertaraNovember 24, 2016

© 2025 Certara. All Rights Reserved. | Privacy policy